Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion

IMPORTANCE: Expanding Medicaid eligibility could affect prescriptions of buprenorphine with naloxone, an established treatment for opioid use disorder, and opioid pain relievers (OPRs). OBJECTIVE: To examine changes in prescriptions of buprenorphine with naloxone and OPRs after the US Affordable Car...

Descripción completa

Detalles Bibliográficos
Autores principales: Saloner, Brendan, Levin, Jonathan, Chang, Hsien-Yen, Jones, Christopher, Alexander, G. Caleb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2018
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324520/
https://www.ncbi.nlm.nih.gov/pubmed/30646116
http://dx.doi.org/10.1001/jamanetworkopen.2018.1588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324520/
https://www.ncbi.nlm.nih.gov/pubmed/30646116
http://dx.doi.org/10.1001/jamanetworkopen.2018.1588

Ejemplares similares